Buprenorphine Treatment: Training for Multidisciplinary Addiction Professionals
Opioid abuse and addiction (e.g., heroin, OxyContin) remains a critical national public health concern.In 2002, tabletformulations of the medication Buprenorphine were approved by the Food and Drug Administration for the treatment of opioid addiction. In order to prepare the field to effectively integrated this new treatment, the Buprenorphine Treatment Blending Team developed an awareness training to disseminate information and enhance awareness among multidisciplinary (non-physician) addiction professionals about Buprenorphine treatment. This training is designed to provide a broad overview of the medication, its effects, and the role of non-physician practitioners in providing and supporting the treatment of individuals receiving this medication.
This is a well thought-out training program, well-designed & well-presented. As a counselor in a treatment program which uses buprenorphine regularly, I learned a great deal about what we're doing, and picked up suggestions to improve the delivery of our services.
Buprenorphine Treatment Blending Team Members
NIDA/ NDAT CTN
- Leslie Amass, Ph.D. - Friends Research Institute, Inc.
- Gregory Brigham, Ph.D. - Maryhaven Community Treatment Program
- Eric Strain, M.D. - Johns Hopkins University
- Thomas Freese, Ph.D. - Pacific Southwest ATTC (Chair)
- Glenda Clare, M.A. - Central East ATTC
- Beth Rutkowski, M.P.H. - Pacific Southwest ATTC
- Gail Dixon, M.A. - Southern Coast ATTC